Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Bicycle Therapeutics PLC Sponsored ADR (BCYC) had Non-Operating Income/Expense of $6.66M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.73M |
|
$-59.10M |
|
-- |
|
$11.73M |
|
$77.28M |
|
$-65.55M |
|
|
Non-Operating Income/Expense |
$6.66M |
$-58.90M |
|
$-58.90M |
|
$-59.10M |
|
$-59.10M |
|
$-59.10M |
|
$-59.10M |
|
$-65.55M |
|
$-63.80M |
|
69.30M |
|
69.30M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$738.82M |
|
$6.86M |
|
$25.14M |
|
$763.95M |
|
$69.28M |
|
-- |
|
$76.19M |
|
$145.47M |
|
$618.48M |
|
$618.48M |
|
$618.48M |
|
69.31M |
|
| Cash Flow Statement Financials | |
$-230.33M |
|
$-1.78M |
|
$-0.12M |
|
$880.07M |
|
$648.87M |
|
$-231.19M |
|
$27.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-558.64% |
|
-558.64% |
|
-- |
|
-501.92% |
|
-503.66% |
|
$-232.10M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.17 |
|
515.91 |
|
-9.56% |
|
-9.56% |
|
-7.74% |
|
-9.56% |
|
$8.92 |
|
$-3.35 |
|
$-3.32 |
|